Get Brenzys Patient Support Program Australia

Official answer. starts to have some effect within one to two weeks, although it may take 3 to 6 months for the full effects to develop. Effects of include less pain, stiffness, and swelling, and improvements in movement and laboratory markers of inflammation.

is a type of medicine known as a biologic. That means it's made from living things, like cells. attaches itself to the TNF proteins to help block their activity. And by lessening the number of active TNF proteins, helps reduce symptoms such as swelling, stiffness, and joint pain.

The recommended dose for adults is 50 mg per week, injected under the skin. Your doctor may determine a different frequency at which to inject Brenzys. If you are being treated for psoriasis, your doctor may prescribe a higher dose of Brenzys when you first begin your treatment.

Drug/comparatorStrengthAverage annual drug cost, $ (Brenzys)50 mg/mL13,244Etanercept (Erelzi)25 mg/0.5 mL 50 mg/mL13,296Golimumab SC ()50 mg/0.5 mL 100 mg/mL18,666Golimumab IV ()50 mg/4.0 mLYear 1: 18,470 Thereafter: 17,19727 more rows

They cause inflammation, which results in symptoms of pain, joint swelling and stiffness, and can lead to joint damage. By blocking the cytokine called Tumour Necrosis Factor (TNF), lessens inflammation, pain symptoms and helps stop further joint damage.

A biosimilar is a type of biologic medication that is designed to be identical to an existing biologic medication, but is created using a different process. Brenzys is a biosimilar of . Both medications are known by the same generic name: . Biosimilars are often cheaper than the original medication.

auto. This medication is typically used for rheumatoid arthritis or for ankylosing spondylitis (arthritis involving the spine). It requires a few weeks to take effect.

MECHANISM OF ACTION is a recombinant DNA-derived protein comprised of Tumor Necrosis Factor Receptor (TNF-R) linked to the Fc portion of human IgG1. binds TNF and blocks its interaction with cell surface receptors.